EnToPath.com
About EnToPath.com
Entopath's overall objective is to commercialize living insect larvae as "bioreactors" for the production of recombinant protein. Insects offer a superior pathway for producing the complex recombinant proteins often required for biopharmaceuticals. The key competitive element to the living larvae technology is the insects produce proteins faster, better, and for much less money than do other recombinant systems.
